Back
  1. Home
  2. Profile of Raphaela Marie Louisa Dierks (ULiège)
Profil

Dierks Raphaela Marie Louisa

Main Referenced Co-authors
Bruyère, Olivier  (3)
Reginster, Jean-Yves  (3)
Richy, Florent  (1)
Main Referenced Keywords
Business model (2); innovations (2); Pharmaceutical industry (2); avenir (1); changements démographiques (1);
Main Referenced Disciplines
Public health, health care sciences & services (3)
Pharmacy, pharmacology & toxicology (2)
Macroeconomics & monetary economics (1)

Publications (total 4)

The most downloaded
2403 downloads
Dierks, R. M. L., Bruyère, O., & Reginster, J.-Y. (2018). Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry. Expert Review of Pharmacoeconomics and Outcomes Research, 18 (2), 147-60. doi:10.1080/14737167.2018.1417040 https://hdl.handle.net/2268/219703

The most cited

12 citations (Scopus®)

Dierks, R. M. L., Bruyère, O., & Reginster, J.-Y. (2018). Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry. Expert Review of Pharmacoeconomics and Outcomes Research, 18 (2), 147-60. doi:10.1080/14737167.2018.1417040 https://hdl.handle.net/2268/219703

Dierks, R. M. L. (2018). A paradigm shift of the pharmaceutical industry: Altering macro and micro-economic factors and its consequences on the business model, innovation and public health [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314856

Dierks, R. M. L., Bruyère, O., & Reginster, J.-Y. (2018). Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry. Expert Review of Pharmacoeconomics and Outcomes Research, 18 (2), 147-60. doi:10.1080/14737167.2018.1417040
Peer Reviewed verified by ORBi

Dierks, R. M. L., Bruyère, O., & Reginster, J.-Y. (2017). Micro Factors Bringing the Pharmaceutical Industry to a Seismic Shaking A Qualitative Research. Expert Review of Pharmacoeconomics and Outcomes Research, 17 (3), 267-74. doi:10.1080/14737167.2017.1351877
Peer Reviewed verified by ORBi

Dierks, R. M. L., Bruyère, O., Reginster, J.-Y., & Richy, F. (October 2016). Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Review of Pharmacoeconomics and Outcomes Research, 16 (5), 571-8. doi:10.1080/14737167.2016.1239534
Peer Reviewed verified by ORBi

Contact ORBi